ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB
Magrey M, Deodhar A, Mease PJ, Navarro-Compán V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup M, Oortgiesen M, et al. (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 1721.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Magrey, M.;
Deodhar, A.;
Mease, P. J.;
Navarro-Compán, V.;
Ramiro, S.;
Rudwaleit, MartinUniBi;
De la Loge, C.;
Fleurinck, C.;
Taieb, V.;
Morup, M.;
Oortgiesen, M.;
Kay, J.
Einrichtung
Stichworte
Quality of life;
Patient reported outcomes;
Spondyloarthritis
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Annals of the Rheumatic Diseases
Band
82
Ausgabe
Suppl. 1
Seite(n)
1721
Konferenz
European Congress of Rheumatology (EULAR)
Konferenzort
Milan, ITALY
Konferenzdatum
2023-05-31 – 2023-06-03
ISSN
0003-4967
eISSN
1468-2060
Page URI
https://pub.uni-bielefeld.de/record/2987170
Zitieren
Magrey M, Deodhar A, Mease PJ, et al. ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):1721.
Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compán, V., Ramiro, S., Rudwaleit, M., De la Loge, C., et al. (2023). ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases, 82(Suppl. 1), 1721. https://doi.org/10.1136/annrheumdis-2023-eular.760
Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compán, V., Ramiro, S., Rudwaleit, Martin, De la Loge, C., et al. 2023. “ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB”, Annals of the Rheumatic Diseases, 82 (Suppl. 1): 1721.
Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compán, V., Ramiro, S., Rudwaleit, M., De la Loge, C., Fleurinck, C., Taieb, V., Morup, M., et al. (2023). ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases 82, 1721.
Magrey, M., et al., 2023. ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases, 82(Suppl. 1), p 1721.
M. Magrey, et al., “ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB”, Annals of the Rheumatic Diseases, vol. 82, 2023, pp. 1721.
Magrey, M., Deodhar, A., Mease, P.J., Navarro-Compán, V., Ramiro, S., Rudwaleit, M., De la Loge, C., Fleurinck, C., Taieb, V., Morup, M., Oortgiesen, M., Kay, J.: ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases. 82, 1721 (2023).
Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compán, V., Ramiro, S., Rudwaleit, Martin, De la Loge, C., Fleurinck, C., Taieb, V., Morup, M., Oortgiesen, M., and Kay, J. “ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB”. Annals of the Rheumatic Diseases 82.Suppl. 1 (2023): 1721.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar